Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.
Steffanie Ung, PharmD Candidate
Advertisement
Articles by Steffanie Ung, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
5
